Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C B Kuo

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Endocrine|December 29, 1998
Prolactin receptor antagonistsC B Kuo, D Coss, A M Walker
Cancer Research|August 17, 2001
A molecular mimic of phosphorylated prolactin markedly reduced tumor incidence and size when DU145 human prostate cancer cells were grown in nude miceX Xu, E Kreye, C B Kuo, et al.
Endocrinology|October 28, 1999
Dissociation of Janus kinase 2 and signal transducer and activator of transcription 5 activation after treatment of Nb2 cells with a molecular mimic of phosphorylated prolactinD Coss, C B Kuo, L Yang, et al.
American Journal of Physiology. Endocrinology and Metabolism|November 30, 2000
Effects of prolactin on osteoblast alkaline phosphatase and bone formation in the developing ratD Coss, L Yang, C B Kuo, et al.
Endocrinology|February 4, 1998
Development of recombinant human prolactin receptor antagonists by molecular mimicry of the phosphorylated hormoneT J Chen, C B Kuo, K F Tsai, et al.
The Journal of Endocrinology|February 22, 2001
Administration of unmodified prolactin (U-PRL) and a molecular mimic of phosphorylated prolactin (PP-PRL) during rat pregnancy provides evidence that the U-PRL:PP-PRL ratio is crucial to the normal development of pup tissuesL Yang, C B Kuo, Y Liu, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Endocrine|December 29, 1998
Prolactin receptor antagonistsC B Kuo, D Coss, A M Walker
Cancer Research|August 17, 2001
A molecular mimic of phosphorylated prolactin markedly reduced tumor incidence and size when DU145 human prostate cancer cells were grown in nude miceX Xu, E Kreye, C B Kuo, et al.
Endocrinology|October 28, 1999
Dissociation of Janus kinase 2 and signal transducer and activator of transcription 5 activation after treatment of Nb2 cells with a molecular mimic of phosphorylated prolactinD Coss, C B Kuo, L Yang, et al.
American Journal of Physiology. Endocrinology and Metabolism|November 30, 2000
Effects of prolactin on osteoblast alkaline phosphatase and bone formation in the developing ratD Coss, L Yang, C B Kuo, et al.
Endocrinology|February 4, 1998
Development of recombinant human prolactin receptor antagonists by molecular mimicry of the phosphorylated hormoneT J Chen, C B Kuo, K F Tsai, et al.
The Journal of Endocrinology|February 22, 2001
Administration of unmodified prolactin (U-PRL) and a molecular mimic of phosphorylated prolactin (PP-PRL) during rat pregnancy provides evidence that the U-PRL:PP-PRL ratio is crucial to the normal development of pup tissuesL Yang, C B Kuo, Y Liu, et al.
Pageof 1